Eagle Asset Management Inc Pfizer Inc Transaction History

Eagle Asset Management Inc

$18.1 Billion
Q2 2024

A detailed history of Eagle Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Eagle Asset Management Inc holds 664,275 shares of PFE stock, worth $18.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

664,275

Previous 518,198 28.19%

Holding current value

$18.2 Million

Previous $14.4 Million 29.26%

% of portfolio

0.1%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $3.69 Million - $4.32 Million	146,077 Added 28.19%	664,275 $18.6 Million
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $10.5 Million - $12 Million	404,725 Added 356.67%	518,198 $14.4 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $2,194 - $2,850	84 Added 0.07%	113,473 $3.27 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $320 - $375	10 Added 0.01%	113,389 $3.76 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $4.45 Million - $5.14 Million	-123,089 Reduced 52.05%	113,379 $4.16 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $4.45 Million - $5.8 Million	113,030 Added 91.57%	236,468 $9.65 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $140,906 - $183,937	-3,375 Reduced 2.66%	123,438 $6.33 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $1.06 Million - $1.29 Million	24,217 Added 23.6%	126,813 $5.55 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $1.27 Million - $1.51 Million	27,299 Added 36.26%	102,596 $5.38 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $3.44 Million - $4.27 Million	75,297 New	75,297 $3.9 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $8.4 Million - $10.8 Million	-213,966 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $1.41 Million - $1.6 Million	39,354 Added 22.54%	213,966 $8.38 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $959,421 - $1.08 Million	-28,648 Reduced 14.09%	174,612 $6.34 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $89.7 Million - $114 Million	-2,678,834 Reduced 92.95%	203,260 $7.48 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $23.3 Million - $27.4 Million	-734,403 Reduced 20.31%	2,882,094 $104 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $1.14 Million - $1.39 Million	-37,972 Reduced 1.04%	3,616,497 $118 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $7.25 Million - $10.4 Million	-268,040 Reduced 6.83%	3,654,469 $119 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $3.48 Million - $3.94 Million	105,574 Added 2.77%	3,922,509 $154 Million
Q3 2019 Nov 04, 2019	BUY	$32.49 - $42.13 $56.9 Million - $73.8 Million	1,752,551 Added 84.89%	3,816,935 $137 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $4.52 Million - $5.08 Million	122,272 Added 6.3%	2,064,384 $89.4 Million
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $18.6 Million - $20.4 Million	-495,416 Reduced 20.32%	1,942,112 $82.5 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $11.6 Million - $13.3 Million	-302,742 Reduced 11.05%	2,437,528 $106 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $23.5 Million - $28.5 Million	-682,041 Reduced 19.93%	2,740,270 $121 Million
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $193,988 - $206,811	-5,882 Reduced 0.17%	3,422,311 $124 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $76,871 - $89,181	-2,409 Reduced 0.07%	3,428,193 $122 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $708,205 - $751,429	21,293 Added 0.62%	3,430,602 $122 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $106 Million - $116 Million	3,409,309	3,409,309 $123 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account

Eagle Asset Management Inc Pfizer Inc Transaction History